Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.
Analysis of the G(-248) polymorphic site in the promoter region of the Bax gene was carried out in 463 CLL patients, showing that 373 (81%) patients were homozygous for the G allele, 84 (18%) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results